Chemoinformaics analysis of 3-METHYL-6-PROPAN-2-YLIDENECYCLOHEX-2-EN-1-ONE
| Molecular Weight | 150.221 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 21 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -2.343 | nHRing | 0 |
| Solubility: LogP | 1.21 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.899 |
| Synth | 4.713 |
| Natural Product Likeliness | 2.242 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.142 |
| Pgp-sub | 0.004 |
| HIA | 0.019 |
| CACO-2 | -4.753 |
| MDCK | 0.0000223 |
| BBB | 0.997 |
| PPB | 0.448034 |
| VDSS | 1.883 |
| FU | 0.606949 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.758 |
| CYP2c19-inh | 0.068 |
| CYP2c19-sub | 0.943 |
| CYP2c9-inh | 0.019 |
| CYP2c9-sub | 0.461 |
| CYP2d6-inh | 0.709 |
| CYP2d6-sub | 0.89 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.869 |
| CL | 14.318 |
| T12 | 0.728 |
| hERG | 0.343 |
| Ames | 0.011 |
| ROA | 0.498 |
| SkinSen | 0.789 |
| Carcinogencity | 0.474 |
| EI | 0.01 |
| Respiratory | 0.925 |
| NR-Aromatase | 0.053 |
| Antiviral | No |
| Prediction | 0.919663 |